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Conclusion: In addition to the predictive value of hsCRP, concentrations of IL-1 beta sig- 
nificantly and independently predicted a step-wise increase in the risk of death or MI. The 
mechanism for CAD risk associated with IL-1 beta independent of IL-6 and hsCRP is 
unknown but suggests complex in rive regulatory networks. Larger studies are needed to 
confirm this finding and to evaluate its implications. 
9:00 a.m. 
841-3 The Combination of Troponin and CRP Levels at 
Admission: A Strong Prognostic Indicator of One-Year 
Morta l i ty  in Both Men and Women With Unstab le  
Coronary Artery Disease 
Stefan K. James. Paul Armstrong, Rob Califf, Agneta Siegbahn, Maarten Simocns, Lars 
Wallentin, the GUSTO-IV trialists, Thoraxcenter, Uppsala, Sweden. 
Background: In acute coronary syndrome (ACS) inflammatory activity and myocardial 
damage as indicated by elevation of the C-reactive protein (CRP) and Troponin T(TnT) 
levels are associated with an impaired clinical outcome. 
Methods: The GUSTO IV ACS trial, evaluating the efficacy of abciximab as the primary 
medical treatment in ACS without early revascularization, included 7800 patients with 
chest pain within 24 hours and either ST-segment depression or elevation of troponin at 
entry. CRP and TnT at randomization from 7108 patients (91%) were determined at the 
core laboratory. CRP (-<1.64, 1.84-3.86, 3.86-9.62, >9.62 mg/I) and Tn T (-<0.01,0.01- 
0.12, 0.12-0.47, >0.47ug/I) were divided into quartiles and its association to mortality at 1 
year follow up was evaluated by Chi2 and multiple logistic regression analysis adjusting 
for other risk factors. 
Results: Mortality at one year; 
The combination of CRP and TnT enhanced the prognostic information with 1.8% modal- 
it,] for men with both markers in the lowest quartile and 16.3% with both markers in the 
highest. For women the corresponding figures where 1.5% and 21.0%, 
CRP and Troponin T quartiles were independently related to mortality even after adjust- 
ment for other established risk factors in multivariate analysis. 
Conclusion: In unstable coronary syndrome the level of CRP and TnT independently pre- 
dicts a higher long term mortality in both men and women. The combination of the mark- 
ers further enhances the tong-term prognostic insight. 
Mortality at one year 
1 Quartiles 3 4 p- 
2 value(trend) 
Males 
TnT 4.3% 7.8% 7.5% 11.4% <0.001 
CRP 5.0% 5.9% 6.4% 14,4% <0,001 
Females 
TnT 3.3% 7.7% 11.7% 17.4% <0.001 
CRP 5,3% 7.6% 9.0% 13.1% <0.001 
9:15 a.m. 
841-4 Low HDL Cholesterol Is a Strong Independent Risk 
Marker in Non-ST Segment Elevation Acute Coronary  
Syndromes 
Juan J. FuselLi. Javier N. Guetta, Carlos P. Boissonnet, Jos~ G(xlia, Alejandro 
Tettamanzi, Silvia Quiroga, Victor Tortes, CEMIC, Buenos Aires, Argentina. 
Background: Lipids are involved in the genesis of acute coronary syndromes (ACS). 
However the utility of lipid measurements during ACS is not known. 
Objective: To analyze the relationship between usual lipid parameters and markers of 
inflammation or myocardial necrosis and prognosis in patients (p) with non-ST elevation 
acute coronary syndrome (NSTEACS). 
Methods: Prospective cohort study of 106 consecutive p admitted with NSTEACS. Base- 
line clinical and ECG data were recorded and blood samples were collected for: a) Lipid 
measurements: Total cholesterol, LDL-C, HDL-C, and tdglycerides (TG)<12 hs from 
admission, b) cEnT end C reactive protein (CRP) 8 to 24 hs from last chest pain episode. 
End point (EP) was death and/or MI, follow up 371±201 days (maximum 830). 
Results: There was a significant correlation between CRP levels with HDL-C (r = -0.36, 
p=0.002) and TG (r = 0.27; p< 0.05). No association was found between cTnT and any 
lipid level. Lower HDL-C levels were associated with worse prognosis (best cut-off point, 
ROC curve: HDL-C <35 mg/dl, Figure). In a Cox regression model including HDL-C, 
cTnT and CRP, HDL-C <35 mg/dl was the strongest independent predictor of EP (HR 
10.2, CI95% 3.1-33.3; p=.001). 
Conclusion: Low HDL-C levels in NSTEACS are associated with elevated CRP, and con- 
stitute a strong independent predictor for shod- and long-term serious events. Further 
studies are needed to determine the precise role of lipid measurements in this population 
and eventually to include them in risk stratification. 
Survival Free of MI 
d0% r_. ~. 
~=0~', i - HDL > 35 rng/dl 
,0~/  ............... i .......... HDL < 35 mg;dl 
0 Dam. 8~3 
ABSTRACTS- Myocardial Infarction and Ischemia 315A 
9:30 a.m. 
841-5 Cl inical  Ut i l i ty of  Myocardial Perfusion Imaging in 
Patients Presenting With Chest  Pain to the Emergency 
Room 
Bharati Shivalkar, Diana Rinkevich, Sanjiv Kaul, Chris Ghaemmaghami, Todd Belcik, 
Kevin Wei, University of Virginia, Charlottesville, Virginia. 
Background: Decreases in coronary driving pressure in the presence of coronary occlu- 
sion or critical coronary stenosis cause capillary derecruitmant which forms the basis for 
resting pedusion defects on myocardial contrast echocardiography (MCE). We therefore 
hypothesized that this technique could be used to distinguish cardiac from non-cardiac 
causes of chest pain in patients presenting to the emergency room (ER), and that peffu- 
sion defects on MCE would provide useful prognostic information. 
Methods: Two hundred patients admitted to the ER with suspected cardiac chest pain 
were included in the study (104 males). Exclusion criteria included age < 40 years, preg- 
nancy or lactation, and allergy to blood components. MCE was performed using continu- 
ous infusion of Optison TM (Mallinckrodt) during intermittent ultraharmonic imaging 
(Agilant). The studies were interpreted by 2 readers blinded to clinical data. Perfusion 
abnormalities present in at least 1 perfusion territory was considered to be positive. 
Results: The MCE studies were interpretable in 153 (77%) patients for all three perfu- 
sion beds. Perlusion defects were seen in 58 patients (38%) on the initial study. The inci- 
dence of cardiac events (including acute myocardial infarction, unstable angina, 
congestive heart failure and cardiac death) was 26% in patients with compared to 3% in 
those without perfusion defects. After a mean follow up of 201 ± 87 days, patients with a 
positive MCE had a significantly higher incidence of myocardial infarction (p<0.001), con- 
gestive heart failure (p=0.O02) and total mortality (p=0.03) compared to patients with nor- 
mal MCE. The incidence of a combined end-point (myocardial infarction, unstable 
angina, heart failure, all-cause death) was also significantly greater in patients with an 
MCE defect (p<0.001). 
Conclusions: MCE can distinguish between cardiac and non cardiac causes of chest 
pain in the ER setting. A positive MCE at the time of patient presentation was associated 
with a significant incidence of early events, and was also highly predictive of a worse 
prognosis during long-term followup. These results may have important clinical implica- 
tions. 
9:45 a.m. 
841-6 Aspirin and Medium Intensity Coumadin Versus Aspirin 
Alone in the Prevention of Reocclusion After 
Successful Thrombolysis for Suspected Acute 
Myocardial Infarction: One-Year Follow-Up of APRICOT- 
2 
Marc A. Brouwer. Paul JP C. van den Bergh, Peter C. Kievit, Wire R M. Aangevaaren, 
Gerdt Veen, Hans E. Luijten, Don P. Hedzbarger, Gerard J H. Uijen, Freek W A. 
Verheugt, UMC Nijmegen, Nijmegen, The Netherlands. 
Background: The APRICOT-2 trial demonstrated that the combination of aspirin with 
medium intensity coumadin (INR 2-3) reduces both angiographic and clinical reocclusion 
in the first three months after successful thrombolysis. We sought to assess whether the 
observed early clinical benefit is sustained at 1 -year follow-up. 
Methods: Patients (n=308) had thrombolytic therapy for suspected acute myocardial inf- 
arction within 6 hours of symptom onset with TIMI 3 flow at angiography < 48 hours. They 
were randomized to either aspirin 80 mg daily, or the combination of aspirin and medium 
intensity coumadin (INR 2-3). Follow-up angiography was scheduled at three months. 
Preliminary one-year clinical follow-up was assessed by Kaplan-Maiar analysis. 
Results: Median follow-up was 305 days(25th,75th percentile 136-507). One-year sur- 
vival without reinfarction was 93% in patients on aspirin combined with coumadin and 
84% in patients on aspirin alone (p<O.01) (figure). Four patients on aspirin and none on 
combination therapy had an ischemic carebrovascular event (p=ns). Total bleeding rates 
were 9% on combination treatment and 4% on aspirin alone (p=ns). 
Conclusions: These preliminary findings suggest that the early clinical benefit of aspirin 
combined with medium intensity coumadin after successful thrombolysis is sustained at 
one-year follow-up. This benefit was achieved with a higher, but acceptable bleeding risk. 
Final data will be presented. 
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